Another Way Fiber Is Filling

Acetate, a short-chain fatty acid released following the fermentation of dietary fiber in the gut, accumulates in the brain and can affect appetite in mice.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Acetate, a molecule produced from fermentation of dietary fiber in the colon, leads to increase anorectic signaling in the hypothalamusCERAN AND PEREZResearchers have long realized that consuming a fiber-rich diet can suppress appetite and reduce food intake in mice and humans alike, a phenomenon previously attributed to the release of gut hormones. Writing in Nature Communications today (April 29), Imperial College London’s Gary Frost and his colleagues showed that small amounts of the short-chain fatty acid acetate, released as a result of the fermentation of dietary fiber in the mouse gut , accumulates within certain neurons in the animal’s hypothalamus, a part of the brain that helps regulate hunger.

For the first time, the researchers have traced “a link between fermentation in the lower part of the gut—the colon—with activity in the brain,” said Patrice Cani, who co-leads the Metabolism and Nutrition Research Group at Université Catholique de Louvain in Belgium, and was not involved in the work. “The originality was to show that acetate can in fact circulate and reach the brain . . . and affect appetite.”

Frost’s team was among the many that had been focusing on gut hormones, such as peptide YY and glucagon-like peptide-1, finding that these could directly affect neurons within the hunger-regulating hypothalamus. But using manganese-enhanced MRI (MEMRI) the researchers found “unusual brain signaling” in appetite-suppressed mice fed a fiber-rich diet, Frost said. “You’d usually expect that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies